Scholars Central

Conference abstract

Vaccine hyporesponse in healthy elderly subjects is associated with a decrease in B cell IFNand#945; responses: Data from functional proteomic analysis using single cell network profiling

Authors: Diane Longo, Brent Louie, Greg Friedl, Erik Evensen, Santosh Putta, Jason Ptacek, Michelle Atallah, David Spellmeyer, Alessandra Cesano, Rachael Hawtin, Andrea Schaeffer, Suzanne Lukac, Radha Railkar, I-Ming Wang, Leon Carayannopoulos

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

P redicting vaccine efficacy has challenged developers for decades. Single cell network profiling (SCNP) is a multiparametric flow cytometry-based approach that simultaneously measures evoked intracellular signaling in multiple and highly specific cell subsets. SCNP technology was used to identify biology associated with vaccine hyporesponse in elderly healthy subjects. Cryopreserved pre-vaccination peripheral blood samples from 174 healthy [144 elderly (>65 years) and 30 young (24-40 years)] subjects vaccinated with tetanus, diphtheria, hepatitis A, hepatitis B, and cholera were examined. Vaccine hyporesponse was defined as non-response to both hepatitis B and cholera based on post-vaccination antibody titers. Twenty-six signaling nodes (extracellular modulator to intracellular readout) were analyzed within 7 distinct immune cell subsets in peripheral blood mononuclear cells. The Wilcoxon rank-sum test was used to identify associations between signaling and vaccine response categories in the elderly cohort. Samples from vaccine hyporesponders showed decreased IFNα-induced JAK/STAT pathway activity in B cells (p<0.05). IFNα responses in B cells were significantly lower in elderly compared with younger donors (p<0.05), suggesting that age-associated SCNP readouts may have clinical utility in predicting vaccine hyporesponse. These data support the potential utility of SCNP to: (1) identify elderly donors less likely to respond to vaccination, (2) provide a greater understanding of the immunological mechanisms underlying vaccine response and lack thereof, and (3) suggest novel targets for vaccine adjuvant development.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Vaccines & Vaccination.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Vaccines & Vaccination
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Diane Longo”
  • BylineArticles whose byline prints “Brent Louie”
  • BylineArticles whose byline prints “Greg Friedl”
  • BylineArticles whose byline prints “Erik Evensen”
  • BylineArticles whose byline prints “Santosh Putta”
  • BylineArticles whose byline prints “Jason Ptacek”
  • BylineArticles whose byline prints “Michelle Atallah”
  • BylineArticles whose byline prints “David Spellmeyer”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels